Prometheus Biosciences Inc Stock, NASDAQ:RXDX
9410 Carroll Park Drive, San Diego, California 92121
United States of America
Number of Employees: 27
Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA .